Skip to main content
. 2014 Aug 29;74(4):875–882. doi: 10.1007/s00280-014-2550-5

Table 3.

GP, FACIT-fatigue, FACT/GOG-neurotoxicity and NPI scores for BDD-A patients

Baseline (N = 13) Cycle 3 (N = 12) End of treatment (N = 10)
Mean (SD) Mean (SD) p valuea Mean (SD) p valueb
GP (Grooved Pegboard)
 Dominant (s) 99.5 (18.9) 103.7 (30.5) 0.443 103.0 (33.1) 0.711
 Non-dominant 94.1 (19.2) 101.2 (22.7) 0.221 94.1 (17.7) 0.326
 FACIT-fatigue 14.9 (11.0) 16.3 (7.7) 0.762 22.4 (11.2) 0.114
 FACT/GOG-neurotoxicity 5.9 (5.4) 8.9 (6.7) 0.113 10.9 (10.0) 0.101
NPI
 Intense 1.8 (2.7) 3.1 (3.2) 0.438 4.5 (3.4) 0.313
 Sharp 1.3 (2.4) 2.8 (3.2) 0.313 2.6 (3.4) 0.875
 Hot 0.3 (0.7) 1.4 (2.4) 0.375 3.3 (3.4) 0.125
 Dull 0.8 (1.5) 2.8 (3.6) 0.125 4.2 (3.0) 0.063
 Cold 0.0 (0.0) 0.9 (1.8) 0.500 2.3 (3.3) 0.250
 Sensitive 0.1 (0.9) 0.9 (1.5) 0.375 3.2 (3.1) 0.031*
 Itchy 0.0 (0.0) 0.3 (0.5) 0.500 1.6 (3.1) 0.250
Total 4.1 (6.3) 12.0 (14.4) 0.406 21.7 (14.2) 0.047*
N (%) N (%) p value N (%) p value
FACIT-fatigue < 30 12 (92) 11 (92) 0.999 8 (80) 0.980
FACIT-GOG NP > 0 8 (62) 9 (75) 0.480 6 (60) 0.999

* Statistically significant p < 0.05

ap value for evaluating changes from baseline to cycle 3

bp value for evaluating changes from baseline to end of treatment